from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1423/whiA

LFCtreatmentdescriptionclass of inhibitor

-0.040

Amikacinug/mL Amikacintranslation

0.602

Cap5-10ug/mL Capreomycintranslation

0.572

Rox10-50 ug/mL Roxithromycintranslation

0.019

SM2-5 ug/mL Streptomycintranslation

-1.842

Tet5-10 ug/mL Tetracyclinetranslation

-0.366

Rif0.2-5ug/mL Rifampicintranscription

1.150

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.604

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.374

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.366

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.949

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.029

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.435

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.628

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.149

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.206

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.435

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.144

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.808

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.345

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.306

KCN5-20 ug/mL Potassium cyaniderespiration

0.858

NaN30.2-2 mM Sodium aziderespiration

0.194

Nigericin50 uM Nigericinrespiration

0.088

TRC10-150 ug/mL Triclosanrespiration

-0.526

TRZ10-25 ug/mL Thioridazinerespiration

0.089

Valinomycin0.5-10 uM Valinomycinrespiration

1.287

ZnSO42 mM ZnSO4respiration

0.317

menadione6-10 ug/mL Menadionerespiration

1.109

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.262

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.710

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.170

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.775

NRP_1Non-replicating persistence stage 1dosRassociated

-0.162

Amp0.2mg/mL AmpicillincellWall

-0.181

Cephalexin20-100 ug/mL CephalexincellWall

0.594

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.739

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.594

EMB10-20 ug/mL EthambutolcellWall

0.192

Eta12-40 ug/mL EthionamidecellWall

0.291

INH0.2-0.4 ug/mL IsoniazidcellWall

0.169

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.594

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.390

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.724

BZA0.12 mg/mL BenzamidearomaticAmides

-0.437

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.162

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.736

H2O24 mM hydrogen peroxideDNAdamaging

0.681

Levo10 ug/mL LevofloxacinDNAdamaging

-0.501

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.846

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.013

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.050

UVUV-irradiationDNAdamaging

1.213

ARP41-4 ug/mL Antitubercular compound ARP4?

0.445

Antimycin12.5-50 ug/mL Antimycin A?

0.760

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.690

PA_110-50 ug/mL Antitubercular compound PA-1?

1.638

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.503

PA8240.2-2 ug/mL PA-824?

0.299

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.884

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.462

Verapamil50 uM Verapamil?

0.706

mercaptoethanol2 mM 2-Mercaptoethanol?

0.733

methoxatin10-20 ug/mL Methoxatin?